Special interview with Dr. Marcela Ciccioli

Neurophth Announces IND Approval by the NMPA for Second Gene Therapy NFS-02 (rAAV2-ND1)

Neurophth's Gene Therapy NR082 Completes Initiation of Multiple Clinical Research Centers in U.S.

Maltese Patient Received World's First ND1-LHON Gene Therapy Injection Donated by Neurophth in China

Commercialization of Gene Therapy is coming soon: Neurophth Completes Patient Enrollment for Phase III clinical trial for the gene therapy treatment of LHON

1st LHON INTERNATIONAL FORUM

41st Annual J.P. Morgan Healthcare Conference 2023 is approaching

Neurophth Receives IND Clearance from FDA for AAV-ND1 Gene Therapy of LHON

Special interview with Dr. Satoshi Kashii on World Sight Day